Skip to content

Pursed Lip Breathing (PLB) and its role in the management of breathlessness in stable chronic obstructive pulmonary disease (COPD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN83029560
Enrollment
46
Registered
2007-09-28
Start date
2006-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory: Chronic obstructive pulmonary disease (COPD) Respiratory Chronic obstructive pulmonary disease (COPD)

Interventions

Pursed Lip Breathing (PLB) vs control

Sponsors

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Prior to July 2008: 1. Non smoking patients that have been diagnosed with COPD who are in a stable condition. 2. 86 participants, broken down as approximately 4/5th will be recruited from The Whittington NHS and 1/5th from Islington PCT. Modified July 2008: 1. Diagnosis of COPD (FEV1 < 80% and FEV1/FVC < 70% predicted) 2. Medical intervention optimised according to NICE guidelines 3. MRC 3 or more; as a minimum walks slower than contemporaries on level ground or has to stop for breathing when walking at own pace 4. 4/52 since last exacerbation and 6/52 since last admission 5.Informed consent obtained and signed after provision of information sheet 6. Able to comply with study procedure

Exclusion criteria

Exclusion criteria: Added July 2008: 1. Subject requires an interpreter for consent form 2. Mini-mental test score < 24 (performed in English) 3. Subject has no fixed abode or does not consent to home visits 4. Hospital Lone Practioner Policy precludes home visits to this subject 5. Previously taught PLB 6. On long term oxygen therapy (LTOT) 7. Medical history preventing ability to walk (other than COPD) 8. Ex-smoker of < 3 months 9. Unstable Angina 10. Uncontrolled hypertension 11. Uncontrolled congestive cardiac failure 12. Uncontrolled cardiac arrhythmias 13. Myocardial infarct within 6 weeks

Design outcomes

Primary

MeasureTime frame
Added July 2008: 1. Chronic Respiratory Disease Questionnaire 2. Endurance Shuttle Walk Test

Secondary

MeasureTime frame
Added July 2008: 1. Borg Dyspnoea Scale 2. Respiratory rate and inspiratory capacity pre and post exercise 3. Hospital Anxiety and Depression scale

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026